Satsuma Pharmaceuticals
Latest round
- Series B
Last raised
- Apr 2019
Total raised
- $68M
Investors
- 11
About Satsuma Pharmaceuticals
Based in California, US, and founded in 2016 by President and CEO John Kollins, Satsuma Pharmaceuticals, Inc. aka Satsuma Pharmaceuticals, operates as a biopharmaceutical company that develops STS101, that is a novel and proprietary investigational drug-device combination product specifically designed to allow intranasal administration of the anti-migraine drug dihydroergotamine (DHE). The company is a publicly-traded company on NASDAQ by STSA and the employee count was 21. In April 2019, Satsuma Pharmaceuticals, Inc. The company develops STS101 which is prepared by combining Satsuma powder technology with a nasal delivery device that is used for acute treatments for migraine. The firm offers a proprietary dry-powder formulation that is a mucoadhesive drug carrier and engineered drug particle technologies. Satsuma Pharmaceuticals provide a nasal delivery device that is its proprietary product. STS101 is evaluated in Phase 3 clinical trials for the acute treatment of migraine.
Who invested in Satsuma Pharmaceuticals
11 investors across 2 rounds
See all investors in Satsuma Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Satsuma Pharmaceuticals
Who invested in Satsuma Pharmaceuticals?
Satsuma Pharmaceuticals has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Satsuma Pharmaceuticals raised?
Satsuma Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Satsuma Pharmaceuticals last raise money?
Satsuma Pharmaceuticals's most recent round on record is a Series B, in Apr 2019.
What does Satsuma Pharmaceuticals do?
Based in California, US, and founded in 2016 by President and CEO John Kollins, Satsuma Pharmaceuticals, Inc.
Where is Satsuma Pharmaceuticals headquartered?
Satsuma Pharmaceuticals is headquartered in San Francisco, US.
Which VCs invest in companies like Satsuma Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Satsuma Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Satsuma Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.